Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-20-024214

Chief Commercial Officer acquired 86,580 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Maloberti Renaud Bertrand Chief Commercial Officer 2020-04-09 Grant or award +86,580 86,580 D: show line 1 in the form
Loading xslF345X03/doc4.xml…